After a positive pregnancy test, I had an ultrasound that raised strong suspicion for a molar pregnancy. A molar pregnancy occurs when abnormal tissue grows inside the uterus instead of a normal placenta, requiring prompt treatment.

Following the ultrasound, I was urgently referred to an obstetrician-gynecologist, and a dilation and curettage (D&C) procedure was performed later that same day. After the procedure, I was discharged home with a small pamphlet and instructions to follow up with the OB-GYN in four weeks.

Through my own research, I learned that after a D&C for a suspected molar pregnancy, patients are typically monitored with regular blood tests measuring beta–human chorionic gonadotropin (beta-hCG). Many guidelines recommend that monitoring begin within 1-2 weeks after the procedure. This follow-up is especially important because, while molar pregnancy is highly treatable, untreated or delayed care can lead to serious complications such as heavy vaginal bleeding, or internal bleeding caused by invasion of the tumor into the uterine wall, and the tumor may begin to spread to other parts of the body.

A definitive diagnosis is made through pathology testing of the tissue removed during the D&C. While pathology results can sometimes return within days, delays of several weeks are not uncommon in Canada. When results are delayed, close monitoring of beta-hCG levels becomes even more critical to guide timely intervention.

Two weeks after my D&C, I contacted the OB-GYN’s office and requested beta-hCG bloodwork. I was told through office staff that I “did not need that test.” I assumed that my surgical report had been reviewed and that the findings must have ruled out a molar pregnancy.

Another two weeks passed while I waited for my follow-up appointment. During that time, I experienced an episode of heavy vaginal bleeding, similar to what I had before the D&C. I contacted the office again, reported the bleeding, and once more requested beta-hCG testing. This time, the OB-GYN agreed to order the bloodwork.

The results were alarming: my beta-hCG level had risen from 780 to 102,000.

When I asked why this bloodwork had not been ordered earlier, I was told that suspected molar pregnancies are rare and that most cases ultimately turn out not to be molar. In effect, because it was uncommon, I had been denied access to this very low cost and simple blood test, even though I had specifically requested it.

By that point, the abnormal tissue had invaded the muscle wall of my uterus, and my condition was now considered an invasive mole which is a type of gestational trophoblastic neoplasia, sometimes referred to as a “cancer of pregnancy.” Because my condition had progressed to this stage, I was no longer a candidate for a less invasive option for my initial condition such as a second D&C, or a laparoscopic hysterectomy. Instead, my options were an open abdominal hysterectomy or several rounds of chemotherapy. I also required CT scans of my lungs and brain to check for possible spread of the disease. I was told chemotherapy was highly likely even after surgery because of the late stage of disease progression.

I learned that the surgical pathology report had in fact confirmed a molar pregnancy, but it had not been performed until almost 6 weeks after my D&C. My OB-GYN did not request the results of the test until I reported heavy bleeding. I was also told that my provider typically waits for pathology results before determining further care. While that approach may be reasonable when pathology returns quickly, it becomes unsafe when results are delayed for several weeks.

This experience taught me how critical self-advocacy is in healthcare. If you or someone you know is told there is a possible molar pregnancy, it is essential to receive prompt treatment and appropriate follow-up. After a D&C for suspected molar pregnancy, patients should ask about beta-hCG monitoring and ensure results are being actively reviewed.

My experience reinforced how essential it is for women to actively advocate for their own health, especially when navigating rare or unfamiliar conditions. If something doesn’t feel right, ask questions. If symptoms persist or worsen, follow up. If you are told that testing or follow-up is not necessary and you are still concerned, it is okay to ask for clarification, request a second opinion, or seek further care. Rare conditions can be overlooked, and delays in follow-up can have serious consequences. Staying informed, keeping track of test results, and ensuring recommended follow-up is arranged can make a critical difference. Women deserve clear answers, timely care, and to be taken seriously. Sharing my story is about helping others recognize warning signs, asking informed questions, and hopefully preventing avoidable harm. I want to share my experience to reach as many people as possible and raise awareness about molar pregnancy, so others can avoid the complications I endured.